166869
Components of genomics and bio-informatics
Monday, November 5, 2007: 3:00 PM
Shankar Srinivasan, PhD
,
Dept of Health Informatics, University of Medicine and Dentistry of New Jersey, Newark,NJ, Newark, NJ, NJ
A balanced overview of health policies that has resounding outcomes on health disparities will be compared and contrasted. Technologically driven means of production in many developed capitalist societies continue to democratize the availability of social services and amenities that are taken for granted in the economically developed nations. On the other hand, interruptions of many social services and extent and obsolete resource-converting techniques have weakened public health infrastructure and the delivery of health care services in many developing nations. The research team will characterize the health profile of political leadership cohorts, middle-income group and lower class by employing vital statistics to illustrate specific inequalities. The overarching objective of this institute is to design unique and culturally competent strategies to eliminate health disparities worldwide. Project participants will be encouraged, in their group sessions to identify technologically appropriate education to correct the existing imbalance in health status among the affluent and impoverished individuals in societies; design pilot programs aimed at correcting health disparities in developed and developing nations and most relevant, construct logic models for implementing programs to alleviate poverty, health disparities and finally, evaluate the short-term and long-term implications of eliminating health disparities worldwide.
Learning Objectives: Describe genomic and biotechnological information for diesease control and wealth creation worldwide.
Presenting author's disclosure statement:Any relevant financial relationships? No Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|